Home » Archive

Articles in the Biology and Medicine Category

Biology and Medicine »

[30 Apr 2010 | No Comment | 5 views]

Fat-free food leads to fat-free bodies. (A moderate amount of fat can also lower the glycemic index of a meal, helping you feel satisfied for longer. )
Energy bars will power weight loss. (Power Bars are processed foods. And processed foods, almost to a rule, can sabotage even the most committed diet)
Grazing will boost metabolism and help you lose weight. (While going too long without eating can set you up for diet catastrophes, “grazing can also rack up calories,” )
Saturated fat causes cellulite, and it’s bad for you anyway. (Cellulite is …

Biology and Medicine, Tech / Science »

[3 Apr 2010 | No Comment | 28 views]

Here are 7 ways we change as we get older :

Old and Dull – Young and Happy

Have a positive attitude
Age could bring happiness for many people
Still enjoy a good laugh
Laughing is good for you, science has shown.
Everything starts to sag
Your skin can be a dead giveaway that you’ve passed the half-century mark
Your stem cells age, too
The scientists suspect genetics is at play.
Need less sleep
Older adults just can’t get the sleep they need
Become more distracted
Seniors might have the unique ability to “hyper-bind” the irrelevant information
Lean liberal
Over …

Biology and Medicine, Tech / Science »

[13 Jan 2010 | One Comment | 433 views]

Related Articles about the MF59 immunologic adjuvant
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
http://content.nejm.org/cgi/content/full/NEJMoa0907650
Background The 2009 pandemic influenza A (H1N1) virus has emerged to cause the first pandemic of the 21st century. Development of effective vaccines is a public health priority. Methods We conducted a single-center study, involving 176 adults, 18 to 50 years of age, to test the monovalent influenza A/California/2009 (H1N1) surface-antigen vaccine, in both MF59-adjuvanted and nonadjuvanted forms.
Novartis Investigational Adjuvanted (MF59) Pre-pandemic Avian Influenza Vaccine Aflunov® Shows Long Lasting, cross-protective Immune Response
http://www.medicalnewstoday.com/articles/148563.php
A study published this week …